Last reviewed · How we verify
Best Supportive Care (BSC) — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Best Supportive Care (BSC) (Best Supportive Care (BSC)) — Janssen Research & Development, LLC. Best Supportive Care (BSC) is a control or comparator arm in clinical trials that provides standard medical management and symptom relief without the investigational drug.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Best Supportive Care (BSC) TARGET | Best Supportive Care (BSC) | Janssen Research & Development, LLC | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Best Supportive Care (BSC) CI watch — RSS
- Best Supportive Care (BSC) CI watch — Atom
- Best Supportive Care (BSC) CI watch — JSON
- Best Supportive Care (BSC) alone — RSS
Cite this brief
Drug Landscape (2026). Best Supportive Care (BSC) — Competitive Intelligence Brief. https://druglandscape.com/ci/best-supportive-care-bsc. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing